Results 81 to 90 of about 2,139,489 (290)

Prognostic Value of Cardiac Troponin I and Left Ventricular Hypertrophy in Mortality of Chronic Hemodialysis Patients [PDF]

Cardiovascular events are the most common cause of death in hemodialysis patients. Cardiac biomarkers and especially Cardiac troponin I has been used as a prognostic marker in hemodialysis patients and there is some controversies about its value.
ذاکری, آناهیتا, قائمیان, ندا, حبیب زاده, شهرام, بشردوست, بهمن   +3 more
core  

Structure-based finite strain modelling of the human left ventricle in diastole [PDF]

, 2013
Finite strain analyses of the left ventricle provide important information on heart function and have the potential to provide insights into the biomechanics of myocardial contractility in health and disease. Systolic dysfunction is the most common cause
Ogden, R.W., Wang, T J, Luo, X.Y., Gao, H, Ogden, R W, Luo, X Y, Wang, T.J., Berry, C, Berry, C., Griffith, B.E., Griffith, B E, Wang, H.M., Gao, H., Wang, H M   +13 more
core   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Diagnostic value of R wave in aVL lead in left ventricular hypertrophy

Universidad Médica Pinareña, 2020
Introduction: left ventricular hypertrophy (LVH) is defined as the increase in the thickness of the wall or the interventricular septal portion (or both). This entity represents an important risk factor that is related to the increase in mortality.
Daniel Alejandro Denis-Piedra, Sheila Martínez-Gutiérrez, Albert Ramón Figueredo-Gilbert, Elia de la Caridad Rodríguez-Venegas   +3 more
doaj   +2 more sources

COMPARISON OF SIGNAL AVERAGED ECG PARAMETERS IN PATIENTS WITH AND WITHOUT LEFT VENTRICULAR HYPERTROPHY

Pakistan Armed Forces Medical Journal, 2022
Objective: Comparison of signal averaged ECG parameters in patients with and without left ventricular hypertrophy. Study Design: Cohort retrospective study.
Bushra Riaz, Syed Muhammad Imran Majeed, Muhammad Alamgir Khan, Madiha Sarwar, Sadia Mubarak   +4 more
doaj   +2 more sources

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

Non-invasive electrical markers in patients with left ventricular hypertrophy.

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2011
Introduction The left ventricular hypertrophy is related with the genesis of ventricular arrhythmiasand sudden death. Depending of the cause, different histologycalmodifications that generate different arrhythmogenic substrates, takesplace.
Nadia Sánchez Torres, Juan A. Álvarez Gómez, Margarita Dorantes Sánchez, Jesús Castro Hevia, Geovedy Martínez García, Irma Fernández Madero   +5 more
doaj  

The incidence and risk factors for new onset atrial fibrillation in the PROSPER study [PDF]

, 2011
Aims Atrial fibrillation/flutter (AF) is the most common arrhythmia in older people. It associates with reduced exercise capacity, increased risk of stroke, and mortality. We aimed to determine retrospectively whether pravastatin reduces the incidence of
Jukema, J.W., R. G. J. Westendorp, Westendorp, R.G.J., P. W. Macfarlane, Sattar, N., J. W. Jukema, Ford, I., D. J. Stott, J. Shepherd, H. Murray, Buckley, B., Murray, H., N. Sattar, B. Buckley, Macfarlane, P.W., Stott, D.J., I. Ford, Shepherd, J.   +17 more
core   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Screening for Fabry Disease in Left Ventricular Hypertrophy: Documentation of a Novel Mutation

Arquivos Brasileiros de Cardiologia, 2015
Background: Fabry disease is a lysosomal storage disease caused by enzyme α-galactosidase A deficiency as a result of mutations in the GLA gene. Cardiac involvement is characterized by progressive left ventricular hypertrophy.
Ana Baptista, Pedro Magalhães, Sílvia Leão, Sofia Carvalho, Pedro Mateus, Ilídio Moreira   +5 more
doaj   +1 more source